InSilico Medicine Cayman TopCo's latest marketcap:
As of 07/19/2026, InSilico Medicine Cayman TopCo's market capitalization has reached $3.35 B. According to our data, InSilico Medicine Cayman TopCo is the 4952th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 3.35 B |
| Revenue (ttm) | 55.84 M |
| Net Income (ttm) | -349,805,524.32 |
| Shares Out | 555.76 M |
| EPS (ttm) | -4.45 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 07/03/2026 |
InSilico Medicine Cayman TopCo's yearly market capitalization.
| Date | Market Cap(HK$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/19/2026 | HK$26.12 B | $3.35 B | -4.27% | 4952 |
| 12/31/2025 | HK$20.64 B | $2.65 B | n/a |
Company Profile
InSilico Medicine Cayman TopCo operates as an artificial intelligence (AI)-based biotech company that helps to develop and manufacture novel drugs in Hong Kong, the United States, the United Kingdom, Mainland China, and internationally.
The company develops solutions to discover and develop drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases.
It also offers Pharma.AI platform, a commercially end-to-end generative Al software and automation platform which is designed to enhance the quality and productivity of pharmaceutical research.
The company was founded in 2014 and is based in New Territories, Hong Kong.
Frequently Asked Questions
-
What is InSilico Medicine Cayman TopCo's (HKG-3696) current market cap?As of 07/19/2026, InSilico Medicine Cayman TopCo (including the parent company, if applicable) has an estimated market capitalization of $3.35 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does InSilico Medicine Cayman TopCo (HKG-3696) rank globally by market cap?InSilico Medicine Cayman TopCo global market capitalization ranking is approximately 4952 as of 07/19/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.